Schizophrenia was primarily associated with dopamine dysfunction. Previous and current treatments have mainly targeted the mesolimbic dopamine pathway in the CNS and D2 receptors. However, the cited review article primarily addresses newer treatment targets and strategies beyond the dopamine hypothesis.
Don‘t have an account? Create new account
Authors: prof. MUDr. Cyril Höschl, DrSc., FRCPsych.
Enter the email address that you registered with. We will send you instructions on how to set a new password.
